Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

44.18
+0.89002.06%
Post-market: 44.180.00000.00%19:30 EDT
Volume:1.25M
Turnover:54.92M
Market Cap:4.80B
PE:-23.88
High:44.68
Open:43.54
Low:43.00
Close:43.29
52wk High:48.40
52wk Low:13.69
Shares:108.60M
Float Shares:88.17M
Volume Ratio:0.94
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8502
EPS(LYR):-1.6302
ROE:-38.03%
ROA:-25.03%
PB:10.71
PE(LYR):-27.10

Loading ...

Edgewise Therapeutics Reports Improvements In Heart Drug Trial

Benzinga
·
Jun 17

Edgewise Therapeutics Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 17

Buy Rating Reiterated on Edgewise Therapeutics as Strong EDG-7500 Data and Asset Sale Support Cardiovascular Pipeline; $45 Price Target Unchanged

TIPRANKS
·
Jun 16

Edgewise Therapeutics falls -9.9%

TIPRANKS
·
Jun 16

BUZZ-Edgewise reports mid-stage trial data for heart disease drug, shares fall

Reuters
·
Jun 16

Edgewise Therapeutics down 25% at $26.55 after EDG-7500 trial update

TIPRANKS
·
Jun 16

Edgewise Therapeutics Advances EDG-7500 to Phase 3 Following 'Positive' HCM Data

MT Newswires Live
·
Jun 16

Edgewise Therapeutics Shares Down 26.3% Premarket After Co Reports Heart Disease Drug Mid-Stage Trial Data

THOMSON REUTERS
·
Jun 16

Edgewise says EDG-7500 posts positive 12-week Phase 2 data in hypertrophic cardiomyopathy trial

Reuters
·
Jun 16

Edgewise Therapeutics Announces Positive Top-Line Data From 12-Week Phase 2 Cirrus-HCM Trial With Edg-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

THOMSON REUTERS
·
Jun 16

Edgewise Therapeutics - No Lvef Reductions Below 50% Observed With Edg-7500

THOMSON REUTERS
·
Jun 16

Edgewise Therapeutics - to Initiate Phase 3 Edg-7500 Program in Q4 2026

THOMSON REUTERS
·
Jun 16

Do New Analyst Upgrades and Option Grants Clarify Edgewise Therapeutics' (EWTX) Long-Term Story?

Simply Wall St.
·
Jun 08

Edgewise Therapeutics Shareholders Back Board and Governance

TIPRANKS
·
Jun 06

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Fate Therapeutics (FATE) and Edgewise Therapeutics (EWTX)

TIPRANKS
·
Jun 06

Edgewise Therapeutics price target raised to $53 from $45 at JPMorgan

TIPRANKS
·
Jun 05

U.S. RESEARCH ROUNDUP-Chipotle Mexican Grill, Honeywell, Tesla

Reuters
·
Jun 05

Edgewise Therapeutics Reports Inducement Grants As Permitted By Nasdaq Listing Rules

Reuters
·
Jun 04

EdgeX offers USDC payments after EDGE liquidations spark scrutiny

cryptonews
·
Jun 04

Edgewise Therapeutics grants 74,000 inducement stock options at $34.16 per share

Reuters
·
Jun 04